Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.83)
# 3,269
Out of 4,984 analysts
173
Total ratings
45.21%
Success rate
-1.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $3.49 | +14.61% | 16 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $107 | $94.19 | +13.60% | 10 | Jul 15, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $160 → $147 | $174.40 | -15.71% | 17 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $99.12 | -4.16% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $434.50 | +49.60% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $15.08 | -20.42% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $119.15 | -20.27% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $77.64 | +9.48% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $39.56 | -62.08% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $332.13 | +3.27% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.58 | +786.08% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $23.87 | +101.09% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $75.09 | +35.84% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $98.98 | -41.40% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $14.90 | +34.23% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $76.55 | +71.13% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $132.76 | +0.18% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $376.62 | -41.59% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $125.82 | +200.43% | 2 | Feb 25, 2022 |
Sight Sciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $3.49
Upside: +14.61%
Medtronic
Jul 15, 2025
Maintains: Overweight
Price Target: $98 → $107
Current: $94.19
Upside: +13.60%
iRhythm Technologies
Jul 15, 2025
Maintains: Overweight
Price Target: $160 → $147
Current: $174.40
Upside: -15.71%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $99.12
Upside: -4.16%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $434.50
Upside: +49.60%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $15.08
Upside: -20.42%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $119.15
Upside: -20.27%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $77.64
Upside: +9.48%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $39.56
Upside: -62.08%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $332.13
Upside: +3.27%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.58
Upside: +786.08%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $23.87
Upside: +101.09%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $75.09
Upside: +35.84%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $98.98
Upside: -41.40%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $14.90
Upside: +34.23%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $76.55
Upside: +71.13%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $132.76
Upside: +0.18%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $376.62
Upside: -41.59%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $125.82
Upside: +200.43%